Amphimak 50 mg Injection 1's

Amphimak 50 mg Injection 1's belongs to a class of medication called 'antifungal' used to treat severe fungal infections like leishmaniasis. A fungal infection is a disease in which fungi attack the tissue and cause infection. Fungi are commonly present in nature but do not cause infections normally. However, if the person has a weak immune system, certain types of fungi may infect them. 

Amphimak 50 mg Injection 1's contains Amphotericin B, which kills fungi by destroying the fungal outer cell membrane. The fungal cell membranes are essential for their survival as they prevent the entry of unwanted substances into the cells and stop the leakage of cell contents.

Amphimak 50 mg Injection 1's is given by a doctor or nurse. In some cases, you may experience fever, chills, irregular heartbeat, high or low blood pressure, breathing problems, nausea, vomiting, headache, shaking, muscle cramps or pain. Most of these side effects of Amphimak 50 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Amphimak 50 mg Injection 1's or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to inform your doctor before using Amphimak 50 mg Injection 1's. Amphimak 50 mg Injection 1's is not recommended for children below one month as the safety and effectiveness were not established. Avoid driving after taking Amphimak 50 mg Injection 1's as it may affect your ability to drive. If you experience severe adverse effects such as chest pain or difficulty in breathing, or encephalopathy (a brain disease which may cause you to behave strangely, be confused or feel drowsy), seek immediate medical help.

Amphimak 50 mg Injection 1's is used in the treatment of Severe fungal infections. The detailed uses of Amphimak 50 mg Injection 1's are as follows:

• Systemic fungal infections: Amphimak 50 mg Injection 1's is used to treat fungal infections including cryptococcosis (especially cryptococcal meningitis), histoplasmosis, blastomycosis, candidiasis (disseminated or invasive), coccidioidomycosis, aspergillosis, sporotrichosis.
• Treatment of mucormycosis: Amphimak 50 mg Injection 1's is used in the treatment of mucormycosis and other rare fungal infections.

• Your doctor will determine the dosage and timing of Amphimak 50 mg Injection 1's based on the severity of your infection. Typically, it is administered once daily.
• Amphimak 50 mg Injection 1's is administered by a healthcare professional in the hospital.
• Do not self-administer it.

Amphimak 50 mg Injection 1's contains Amphotericin B, an antifungal used to treat severe fungal infections. The fungal cell membranes are essential for their survival as they prevent the entry of unwanted substances into the cells and stop the leakage of cell contents. Amphimak 50 mg Injection 1's damages fungal cell membranes and kills fungi. Amphimak 50 mg Injection 1's is used to treat infections such as blood infection with candida, cryptococcus, fusarium, zygomycetes, aspergillus, coccidiodes or blastomycetes, or cryptococcal meningitis (inflammation of the brain).

If you are allergic to Amphotericin B or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using Amphimak 50 mg Injection 1's. Amphimak 50 mg Injection 1's is not recommended for children below one month as the safety and effectiveness were not established. Avoid driving after taking Amphimak 50 mg Injection 1's as it may affect your ability to drive. If you experience severe adverse effects such as chest pain, difficulty breathing, or encephalopathy (a brain disease that may cause you to behave strangely, be confused or feel drowsy), seek immediate medical help. If you have diabetes, electrolyte imbalance (low magnesium or potassium levels in the blood), kidney, liver or heart problems, inform your doctor before taking Amphimak 50 mg Injection 1's.